Reduce the global burden of RSV infection
Our new RSV Dasboard is now live! It gives insight into RSV data from 20 different countries.
This is how you can help: participate in our survey and spread the word!
Help us understand parents’ awareness of RSV, and their needs when vaccinating their child. It will only take 2-3 minutes of your time.
Paper of the Month: May 2023
Prioritising respiratory syncytial virus prevention in low-income and middle-income countries
Xavier Carbonell-Estrany et al.
RSV disease burden in children below 5 in 72 GAVI eligible countries.
Image from: Li, X. et al. BMC Med 18, 82 (2020). https://doi.org/10.1186/s12916-020-01537-6
Over the past few years, the advent of several preventive interventions finally provides opportunities to address the burden of respiratory syncytial virus disease. However, in the past, new vaccines…
We are proud to announce we have developed the first-ever global RSV surveillance dashboard and it is now live!
ReSViNET Foundation, in collaboration with AstraZeneca, is supporting healthcare decisions by providing transparency and accessibility to shared global RSV surveillance data. The dashboard will help simplify tracking changes in RSV seasonality globally. This will include at least 20 countries that are representative of different geographic regions from both hemispheres.
RSVVW’24 Conference Mumbai
We are delighted to announce that on 13-16 February 2024, the ReSViNET Foundation will host its 8th conference RSVVW’24 – A Global Conference on Novel RSV Preventive and Therapeutic Interventions. After a successful conference in 2022, held in Lisbon, Portugal, we are looking forward to welcoming you at our next in-person conference in Mumbai, India.
Connecting research and society
The ReSViNET Foundation is the first and leading global non-profit organisation fully committed to reducing the global burden of the Respiratory Syncytial Virus (RSV).
We collaborate with researchers, the health sector, governments, international statutory bodies, non-profit organisations and the wider civil society in an effort to coordinate actions and raise awareness about RSV infection and to tackle the challenge of RSV infection prevention and treatment.
A global health challenge
Every year, Respiratory Syncytial Virus (RSV) affects more than 33 million children under 5 years worldwide. It is one of our most significant global healthcare challenges, not only in infants, but also in older adults. ReSViNET is the first official RSV foundation and aims to provide a platform for global collaborations to raise awareness about RSV infection and stimulate the development of RSV prevention and treatment.